William Blair Investment Management LLC decreased its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 2.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 749,688 shares of the technology company’s stock after selling 16,179 shares during the period. William Blair Investment Management LLC’s holdings in Novanta were worth $106,598,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of NOVT. State Street Corp grew its stake in Novanta by 7.3% in the 2nd quarter. State Street Corp now owns 1,436,785 shares of the technology company’s stock worth $233,005,000 after acquiring an additional 97,621 shares during the period. Tidal Investments LLC raised its holdings in Novanta by 615.8% in the 2nd quarter. Tidal Investments LLC now owns 34,631 shares of the technology company’s stock valued at $5,619,000 after acquiring an additional 29,793 shares during the last quarter. Bank of America Corp DE raised its holdings in Novanta by 18.3% in the 1st quarter. Bank of America Corp DE now owns 456,241 shares of the technology company’s stock valued at $53,887,000 after acquiring an additional 70,728 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in shares of Novanta during the 2nd quarter worth $5,797,000. Finally, Bamco Inc. NY purchased a new position in shares of Novanta during the 2nd quarter worth $137,984,000. Hedge funds and other institutional investors own 98.35% of the company’s stock.
Analysts Set New Price Targets
NOVT has been the topic of several analyst reports. Zacks Research cut Novanta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Weiss Ratings lowered Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, November 10th. Robert W. Baird dropped their target price on Novanta from $194.00 to $175.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a research report on Sunday. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Novanta has a consensus rating of “Hold” and an average price target of $175.00.
Read Our Latest Stock Report on NOVT
Novanta Price Performance
Shares of NASDAQ NOVT opened at $118.88 on Monday. The stock has a market capitalization of $4.50 billion, a PE ratio of 90.75, a P/E/G ratio of 2.58 and a beta of 1.71. The company has a quick ratio of 0.76, a current ratio of 1.18 and a debt-to-equity ratio of 0.48. The firm has a fifty day moving average of $140.29 and a 200-day moving average of $142.25. Novanta Inc. has a 52-week low of $98.27 and a 52-week high of $176.38.
Novanta (NASDAQ:NOVT – Get Free Report) last issued its earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.08. Novanta had a return on equity of 10.23% and a net margin of 4.89%. The business had revenue of $305.01 million for the quarter, compared to analyst estimates of $301.02 million. During the same period last year, the company posted $0.87 EPS. The business’s quarterly revenue was up 23.1% on a year-over-year basis. On average, analysts anticipate that Novanta Inc. will post 3.68 EPS for the current year.
Novanta Profile
Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Novanta
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
